Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

OBJECTIVE: This study aims to establish the benefits of lowering cholesterol in diabetic patients with well-controlled hypertension and average/below-average cholesterol concentrations, but without established coronary disease. RESEARCH DESIGN AND METHODS: In the lipid-lowering arm of the Anglo-Sca...

Full description

Bibliographic Details
Main Authors: Sever, P, Poulter, N, Dahlöf, B, Wedel, H, Collins, R, Beevers, G, Caulfield, M, Kjeldsen, SE, Kristinsson, A, McInnes, G, Mehlsen, J, Nieminen, M, O'Brien, E, Ostergren, J
Format: Journal article
Language:English
Published: 2005

Similar Items

Similar Items